Global Mouth Ulcers Treatment Market Sees Steady Progress with Increased Focus on Oral Ulcerations

May 2022

Growing emphasis on oral health has earned oral ulcerations significant recognition around the world. Inflammatory bowel diseases are among the major causes of mouth ulcers; however, oral cancer patients have also shown susceptibility to such ailments. During the forecast period, the growing pervasiveness of such conditions is poised to drive growth across the global mouth ulcers treatment market. In addition, the incidence of oral herpes and cold sores in and around the mouth are further fueling market expansion.

Besides, with the rising geriatric population, the incidence of mouth ulcers has become more prominent. Anticipating these trends, the market is set to expand significantly in the coming years. Fairfield Market Research predicts promising growth prospects for the global mouth ulcers treatment market. Rising from US$1.6 Mn worth in 2021 to US$2.0 Bn in 2026, the market is projected to witness sustained growth at a CAGR of 3.9% during the assessment period of 2021 to 2026. 

Key Trends Across Global Mouth Ulcers Treatment Market:

  • During the projection time frame, analgesics and corticosteroids are the most coveted segment by drug class

  • Aphthous stomatitis is among the most prominent indication that creates significant demand for mouth ulcers treatment

  • A consistent uptick in sales of mouthwash is assuring influential growth across the mouth ulcers treatment market in the US.

Rising Prevalence of Chronic Health Conditions Creates Headways for Market Expansion

From the general population to the cancer-afflicted populace, the incidence of mouth ulcers has risen at a record pace. Among individuals, mouth ulcers are considered a major factor causing morbidity and requiring medical consultation. To this end, there has been a significant push in social and healthcare burdens. Growing awareness of available treatment options to minimise the side effects and alleviate the symptoms is channelling substantial growth across the mouth ulcers treatment market. The accelerated pace of technological innovation in products in the healthcare industry has been reported, lately. Moreover, individuals are demonstrating a higher propensity to spend on prescription and over-the-counter treatments which shall save time and money. That said, the global mouth ulcers treatment market is paving its way to sound fruition.

North America Claims Major Share in Market Revenue Owing to Dramatic Rise in Oral Cancer Cases

North America exhibits greater grit in the global mouth ulcer treatment market, and other regional markets such as Europe and Asia Pacific are following suit. National Dental Advisory Board (NDAB) reports that mouthwash products are used by almost 45 million individuals in America. The report further states the incidence of almost 2 million new oral cancer-related diseases. These aspects are driving the demand for mouth ulcer treatment in North America. Besides, the growing geriatric population and changing lifestyles in economies, such as India and China, are serving as major growth enablers for the mouth ulcers treatment market in the region. Emerging economies, including India, South Korea, Japan, and China are experiencing steep rises in disposable income levels, further strengthening the growth prospects of the regional market. 

Distinguished Market Players

Some of the most influential players consolidating a strong foothold in the global mouth ulcers treatment market are Pfizer, Inc., Bristol-Myers Squibb Company, Blistex Inc., Inc., Colgate-Palmolive Company, Church & Dwight Co., 3M, Patterson Companies, Inc., Dr. Reddy’s Laboratories Ltd, and GlaxoSmithKline plc.